Log in to save to my catalogue

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevan...

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11029306

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

About this item

Full title

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Cancer Immunology, Immunotherapy, 2016-01, Vol.65 (1), p.47-59

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Reduced expression of HLA class I is an important immune escape mechanism from cytotoxic T cells described in various types of malignancy. It often correlates with poor prognosis and resistance to therapy. However, current knowledge about the frequency, underlying molecular mechanisms, and prognostic value of HLA class I and II alterations in prost...

Alternative Titles

Full title

Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11029306

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11029306

Other Identifiers

ISSN

0340-7004

E-ISSN

1432-0851

DOI

10.1007/s00262-015-1774-5

How to access this item